LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Biologics/Oxygen-Deprived Stem Cells More Effective at Making Bone
Biologics

Oxygen-Deprived Stem Cells More Effective at Making Bone

July 10, 2018 2 min read Premium comments

Advertisement

Oxygen-Deprived Stem Cells More Effective at Making Bone
Source: Wikimedia commons and US FDA
Secondary#stemcells#bonedefects#hypoxicconditioning

Depriving stem cells of oxygen and forming them into spheroids before using them to treat bone defects increases their ability to form new bone and repair existing bone, according to a new study led by Kent Leach, Ph.D., a professor of Biomedical Engineering and Orthopaedic Surgery at the University of California, Davis.

The periodical Stem Cells published the study (“Hypoxic Preconditioning of Mesenchymal Stem Cells with Subsequent Spheroid Formation Accelerates Repair of Segmental Bone Defects”) and is the source for the information in this article.

“Cell-based approaches for musculoskeletal tissue repair are limited by poor cell survival and engraftment,” Leach said. “Cells are initially delivered to harsh environments that lack oxygen. We already knew that short-term hypoxic (low oxygen levels) preconditioning of mesenchymal stem cells (MSCs) can prolong cell viability in lab culture, while forming the MSCs [mesenchymal stem cells] into spheroids increases cell survival, trophic factor secretion and tissue formation in vivo.

“So, we hypothesized that preconditioning the MSCs in hypoxia culture before being formed into spheroids might boost the cells’ survival rate and help them to perform better.”

He was right.

To test their theory, the researchers exposed a single-layered culture of human MSCs to 1% oxygen for three days. A control group of cells was limited to ambient air only. Both groups were then formed into spheroids in an engineered hydrogel carrier. The researchers found that the oxygen-deprived cells had a better survival rate than the control group—a factor that increased with the amount of time the cells were exposed to the hypoxic preconditioning.

The next step was to test how the spheroids performed in treating bone defects in rats. They tested spheroids of cells deprived of oxygen against those that were not deprived. They also examined how the spheroids of cells performed compared to oxygen-restricted single cells. “Once again, the oxygen-deprived, spheroid-containing gels induced significantly more bone healing than did gels containing either preconditioned individual MSCs or acellular gels,” Leach said.

He added, “We believe these data demonstrate that preconditioning the cells with a low level of oxygen represents a simple approach for enhancing the therapeutic potential of MSC spheroids when used for bone healing.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy